Leslie R. Harrold

11.1k citations

168 papers · 6.9k indexed · 1 hit paper · h-index 41

Geriatrics and Gerontology top 0.1%
Family Practice top 0.2%
Rheumatology top 0.2%
- Rheumatoid Arthritis Research and Therapies 98
- Systemic Lupus Erythematosus Research 43
Toxicology top 0.2%
Nephrology top 0.5%
- Gout, Hyperuricemia, Uric Acid 16
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 29
Genetics
- Chronic Lymphocytic Leukemia Research 26
Hematology
- Autoimmune and Inflammatory Disorders Research 24
Immunology
- Psoriasis: Treatment and Pathogenesis 13
Hepatology
- Hepatitis C virus research 13

Co-authors: Jerry H. Gurwitz Terry S. Field George Reed David W. Bates Susan E. Andrade Leslie Fish Lawrence Garber Joel M. Kremer
Cited by: Geriatrics and Gerontology Family Practice Rheumatology
Partner nations: United States Canada Sweden

In The Last Decade

Leslie R. Harrold

168 papers receiving 6.6k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2003 Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting

Peers

Countries citing papers authored by Leslie R. Harrold

Since Specialization

Citations

This map shows the geographic impact of Leslie R. Harrold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie R. Harrold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie R. Harrold more than expected).

Fields of papers citing papers by Leslie R. Harrold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie R. Harrold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie R. Harrold. The network helps show where Leslie R. Harrold may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Leslie R. Harrold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Leslie R. Harrold Line = papers co-authored together Leslie R. Harrold links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Metabolic Syndrome, Adipokines, and Response to Advanced Therapies in Rheumatoid Arthritis Joshua F. Baker,George Reed,Ted R. Mikuls,Geoffrey M. Thiele,Dimitrios A. Pappas,Christina Charles‐Schoeman,Mónica Gumá,Leslie R. Harrold,Jeffrey R. Curtis,Joel M. Kremer	2024	2
2	Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positive Leslie R. Harrold,Keith Wittstock,Sheila Kelly,Xue Han,Joe Zhuo,Amy Schrader,Nicole Middaugh,Page C. Moore,Vadim Khaychuk	2024	1
3	Rheumatologist and Patient Mental Models for Treatment of Rheumatoid Arthritis Help Explain Low Treat‐to‐Target Rates Betty Hsiao,Julie S. Downs,Mandy Lanyon,Susan J. Blalock,Jeffrey R. Curtis,Leslie R. Harrold,W. Benjamin Nowell,Carole Wiedmeyer,Shilpa Venkatachalam,Liana Fraenkel	2022	3
4	Obesity and Response to Advanced Therapies in Rheumatoid Arthritis Joshua F. Baker,George Reed,Dilli Ram Poudel,Leslie R. Harrold,Joel M. Kremer	2022	14
5	Descriptive Comparisons of the Effect of Apremilast and Methotrexate Monotherapy in Oligoarticular Psoriatic Arthritis: The Corrona Psoriatic Arthritis/Spondyloarthritis Registry Results Alexis Ogdie,Mei Liu,Meghan Glynn,Kelechi Emeanuru,Leslie R. Harrold,Sven Richter,B. Guérette,Philip J. Mease	2020	9
6	Real‐World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis Jeffrey R. Curtis,J. Lynn Palmer,George Reed,Jeffrey D. Greenberg,Dimitrios A. Pappas,Leslie R. Harrold,Joel M. Kremer	2020	11
7	Characterization of insufficient responders to anti-tumor necrosis factor therapies in patients with moderate to severe psoriasis: real-world data from the US Corrona Psoriasis Registry Abby S. Van Voorhees,Marc A. Mason,Leslie R. Harrold,Ning Guo,Adriana Guana,Haijun Tian,Vivian Herrera,Bruce Strober	2019	16
8	Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis Siri Lillegraven,Jeffrey D. Greenberg,George Reed,Katherine C. Saunders,Jeffrey R. Curtis,Leslie R. Harrold,Marc C. Hochberg,Dimitrios A. Pappas,Joel M. Kremer,Daniel H. Solomon	2019	39
9	Do Poor Prognostic Factors in Rheumatoid Arthritis Affect Treatment Choices and Outcomes? Analysis of a US Rheumatoid Arthritis Registry E. Alemao,Heather J. Litman,Seán Connolly,Sheila Kelly,Winnie Hua,Lisa Rosenblatt,Sabrina Rebello,Joel M. Kremer,Leslie R. Harrold	2018	2
10	A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice? Leslie R. Harrold,Heather J. Litman,Seán Connolly,Sheila Kelly,Winnie Hua,E. Alemao,Lisa Rosenblatt,Sabrina Rebello,Joel M. Kremer	2017	13
11	Effect of Anticitrullinated Protein Antibody Status on Response to Abatacept or Antitumor Necrosis Factor-α Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study Leslie R. Harrold,Heather J. Litman,Seán Connolly,Sheila Kelly,Winnie Hua,E. Alemao,Lisa Rosenblatt,Sabrina Rebello,Joel M. Kremer	2017	39
12	The Association Between Serum Uric Acid Levels and Acute Myocardial Infarction in Incident Gout Patients TC Cheetham,Nichols Ga,Leslie R. Harrold,MA Schmidt,LM Reifler,David Tabano,MA Raebel	2016	1
13	Web-based Comparative Patient-reported Outcome Feedback to Support Quality Improvement and Comparative Effectiveness Research in Total Joint Replacement Hua Zheng,Wenjun Li,Leslie R. Harrold,David C. Ayers,Patricia D. Franklin	2014	15
14	The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor Leslie R. Harrold,George Reed,Joel M. Kremer,Jeffrey R. Curtis,Daniel H. Solomon,Marc C. Hochberg,Jeffrey D. Greenberg	2013	51
15	A systematic review of validated methods for identifying heart failure using administrative data Jane S. Saczynski,Susan E. Andrade,Leslie R. Harrold,Jennifer Tjia,Sarah L. Cutrona,Katherine Dodd,Robert J. Goldberg,Jerry H. Gurwitz	2012	214
16	A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registry Jeffrey D. Greenberg,George Reed,Dennis L. Decktor,Leslie R. Harrold,Daniel E. Furst,Allan Gibofsky,Ralph DeHoratius,Mitsumasa Kishimoto,Joel M. Kremer	2012	128
17	Time Trends in Medication Use and Expenditures in Older Patients with Rheumatoid Arthritis Leslie R. Harrold,Daniel J. Peterson,Ashley Beard,Jerry H. Gurwitz,Becky A. Briesacher	2012	23
18	Evaluation of composite measures of treatment response without acute-phase reactants in patients with rheumatoid arthritis J.D. Greenberg,Leslie R. Harrold,Michael J. Bentley,J.M. Kremer,G. Reed,Vibeke Strand	2009	26
19	Identification of Patients With Arthritis and Arthritis-Related Functional Limitation Using Administrative Data Leslie R. Harrold,Wenjun Li,Robert A. Yood,Jackie Fuller,Jerry H. Gurwitz	2008	2
20	Physician Attitudes Concerning Anticoagulation Services in the Long-Term Care Setting Leslie R. Harrold,Jerry H. Gurwitz,Janet P. Tate,Richard C. Becker,Tammy L. Stuart,Anne Elwell,Martha J. Radford	2002	6

About Leslie R. Harrold

Leslie R. Harrold is a scholar working on Rheumatology, Geriatrics and Gerontology and Genetics, having authored 168 papers that have together received 6.9k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (98 papers), Systemic Lupus Erythematosus Research (43 papers), Lymphoma Diagnosis and Treatment (29 papers), Chronic Lymphocytic Leukemia Research (26 papers), Autoimmune and Inflammatory Disorders Research (24 papers), Gout, Hyperuricemia, Uric Acid (16 papers), Psoriasis: Treatment and Pathogenesis (13 papers) and Hepatitis C virus research (13 papers). The work is most often cited by research in Geriatrics and Gerontology (1.6k citations), Family Practice (531 citations) and Rheumatology (2.6k citations). Leslie R. Harrold has collaborated with scholars based in United States, Canada and Sweden. Frequent co-authors include Jerry H. Gurwitz, Terry S. Field, George Reed, David W. Bates, Susan E. Andrade, Leslie Fish, Lawrence Garber, Joel M. Kremer, Jeffrey R. Curtis and Andrew C. Seger.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact